Early-career translational clinical-oncology grants to advance lung cancer detection, diagnostics, therapy selection, side-effect minimization, outcomes, and access—prioritizing projects with near-term patient impact and benefits for underrepresented populations.
Eligibility Criteria:
-
IASLC member; doctoral degree (MD, DO, PhD, PharmD, ScD or equivalent).
-
Instructor/Assistant/Associate Professor (or equivalent); full professors ineligible.
-
Within 7 years of residency/fellowship (physicians) or postdoc (lab scientists); limited exceptions possible.
-
No prior LCFA grant; not PI on R01/DOD-equivalent or ≥125,000 USD/year ×3 years peer-reviewed awards (mentored K/CDAs allowed).
-
Institutional commitment ~50% effort for the applicant.
Funding Details:
-
100,000 USD per year for up to 2 years (year 2 contingent on satisfactory progress and funds availability).
-
≤50% of budget for salary/benefits; no indirects; no permanent equipment; travel capped at 1,000 USD/year.
Deadline:
-
Application Deadline: January 8, 2026.
- Applicants Notified: By May 15, 2026.
Where To Go For Further Information:
-
Questions: [email protected].